4//SEC Filing
File Justin J. 4
Accession 0001618835-20-000020
CIK 0001618835other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:32 PM ET
Size
9.5 KB
Accession
0001618835-20-000020
Insider Transaction Report
Form 4
File Justin J.
Chief Financial Officer
Transactions
- Award
Common Stock
2020-02-05$5.21/sh+3,846$20,038→ 181,097 total - Award
Common Stock
2020-02-05+150,000→ 331,097 total - Award
Stock option (right to buy)
2020-02-05+100,000→ 100,000 totalExercise: $4.87Exp: 2030-02-05→ Common Stock (100,000 underlying)
Footnotes (5)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Evofem Biosciences, Inc. 2019 Employee Stock Purchase Plan (2019 ESPP), for the ESPP purchase period of June 17, 2019 through December 13,2019. This transaction is also exempt under Rule 16b-3(c).
- [F2]The reporting person is voluntarily reporting this transaction as of February 5, 2020, but the actual transaction took place on December 13, 2019, the last trading day of the purchase period under the 2019 ESPP.
- [F3]In accordance with the 2019 ESPP, these shares were purchased based on 85% of the closing stock price on December 13, 2019, the last trading day of the purchase period.
- [F4]The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2020.
- [F5]The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 5, 2020.
Documents
Issuer
Evofem Biosciences, Inc.
CIK 0001618835
Entity typeother
Related Parties
1- filerCIK 0001726277
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:32 PM ET
- Size
- 9.5 KB